A Study to Evaluate the Effect of Famciclovir in Reducing Herpes Virus Shedding

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
The study is designed to assess the efficacy and safety of famciclovir 250 mg twice a day (bid) suppressive treatment in men and women with herpes virus type 2 (HSV-2) infection, with and without a reported history of genital herpes and with or without herpes virus type 1 (HSV-1) seropositivity.
Epistemonikos ID: 5149d61de59d58c90736bff3d519ddac6a20b849
First added on: Mar 23, 2020